Keerthi Vedantam / Crunchbase News:
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ — This is not your average raise. — Biotech upstart Tempus announced on Thursday it raised $275 million through equity …
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News)
By 
Add A Comment
